Mary Ann Leeper

Last updated

Mary Ann Leeper is the founder of the Female Health Foundation (1994) where she became the chair and board member. She was president and COO for ten plus years before retiring in 2013. Leeper also co-founded another organization called the Business Woman's Initiative against HIV/AIDS. [1] With Leeper's aid, the newest version of the female condom will be introduced to women in locations with high rates of HIV/AIDS. The launch of this new female condom is cheaper and will reach more women. Leeper gives lectures and presentations in colleges and universities across the world. [1] Her main goal is to “help millions of women protect themselves against the spread of HIV and AIDS”. She also stated, “It is not a simple goal, but it is one I am determined to do everything possible to achieve.”

Contents

Education

Mary Ann Leeper earned her Bachelor of Science at Drexel University. She received a Master of Science at Temple University. Leeper later received her master's degree in business at Northwestern University's Kellogg Graduate School of Management. She returned to Temple University to study for her doctorate in pharmaceutical chemistry. [2]

Career

Before retirement, Leeper gave lectures to colleges and universities regarding global entrepreneurship, gender bias, corporate social responsibility, women's issues in the developing world, and prevention programs against HIV/AIDS. [3] She was also an assistant professor at Temple University Schools of Pharmacy and Medicine along with being a biochemist and director of Neenah Paper Company. Her main focus and overall works revolve around global entrepreneurship, gender bias, women's issue in the world, and lastly female sexual health and protection. [2]

Female condom

Her most recent contribution was the launch of the female condom. She switched from polyurethane material to synthetic latex, which overall saves manufacturing costs and makes the condom much more affordable. The female condom is an over the counter contraceptive, which has been FDA approved for over 20 years. The female condom gives females an option in choosing the best contraceptive, while remaining sexually active. The female condom contains just as high of a success rate as the male condom. It has between 93% and 95% pregnancy prevention success, which is lower than oral contraceptives, injectables, or the IUD. [4]

Awards

United Nation have given her various recognition awards for her work on women's sexual and reproductive health.[ citation needed ]
Women's Entrepreneurship from Temple University's School of Business (November 2003) [ citation needed ] As a senior strategic advisor, Leeper has received several prestigious awards, starting from the University of Temple and a recognition award in 2005 and certain United Nations and global health agencies. Along with Mary Ann Leepers’ amazing accomplishments, she also plays a big role in theFemale Health Company’s. She gathers with the MAC, CDC, Department of Health, Female Health Company, and CVS to discuss her personal goal to make female condoms a strong accessible to all women in the country. [5]

Boards/Committees

Related Research Articles

<span class="mw-page-title-main">Condom</span> Device for birth control and STI prevention

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use—and use at every act of intercourse—women whose partners use male condoms experience a 2% per-year pregnancy rate. With typical use, the rate of pregnancy is 18% per-year. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis.

<span class="mw-page-title-main">Safe sex</span> Ways to reduce the risk of acquiring STIs

Safe sex is sexual activity using methods or contraceptive devices to reduce the risk of transmitting or acquiring sexually transmitted infections (STIs), especially HIV. "Safe sex" is also sometimes referred to as safer sex or protected sex to indicate that some safe sex practices do not eliminate STI risks. It is also sometimes used colloquially to describe methods aimed at preventing pregnancy that may or may not also lower STI risks.

<span class="mw-page-title-main">Sexual and reproductive health</span> State of the reproductive system without evidence of disease, disorders, or deficiencies

Sexual and reproductive health (SRH) is a field of research, health care, and social activism that explores the health of an individual's reproductive system and sexual well-being during all stages of their life.

<span class="mw-page-title-main">HIV/AIDS in South Africa</span> Health concern in South Africa

HIV/AIDS is one of the most serious health concerns in South Africa. The country has the highest number of people afflicted with HIV of any country, and the fourth-highest adult HIV prevalence rate, according to the 2019 United Nations statistics.

Abstinence, be faithful, use a condom, also known as the ABC strategy or abstinence-plus sex education, also known as abstinence-based sex education, is a sex education policy based on a combination of "risk avoidance" and harm reduction which modifies the approach of abstinence-only sex education by including education about the value of partner reduction safe sex and birth control methods. Abstinence-only sex education is strictly to promote the sexual abstinence until marriage, and does not teach about safe sex or contraceptives. The abstinence-based sex education program is meant to stress abstinence and include information on safe sex practices. In general terms, this strategy of sex education is a compromise between abstinence-only education and comprehensive sex education. The ABC approach was developed in response to the growing epidemic of HIV/AIDS in Africa, and to prevent the spread of other sexually transmitted diseases. This approach has been credited by some with the falling numbers of those infected with AIDS in Uganda, Kenya and Zimbabwe, among others. From 1990 to 2001 the percentage of Ugandans living with AIDS fell from 15% to between 5 and 6%. This fall is believed to result from the employment of the ABC approach, especially reduction in the number of sex partners, called "Zero-Grazing" in Uganda.

<span class="mw-page-title-main">PATH (global health organization)</span> Global health nonprofit

PATH is an international, nonprofit global health organization. PATH is based in Seattle with 1,600 employees in more than 70 countries around the world. Its president and CEO is Nikolaj Gilbert, who is also the Managing Director and CEO of Foundations for Appropriate Technologies in Health (FATH), PATH's Swiss subsidiary. PATH focuses on six platforms: vaccines, drugs, diagnostics, devices, system, and service innovations.

<span class="mw-page-title-main">Female condom</span> Device for birth control and STI prevention

An internal condom is a barrier device that is used during sexual intercourse as a barrier contraceptive to reduce the probability of pregnancy or a sexually transmitted infection (STI). Meant as an alternative to the condom, it was invented by Danish MD Lasse Hessel and designed to be worn internally by the woman during vaginal sex to prevent exposure to semen or other body fluids. His invention was launched in Europe in 1990 and approved by the FDA for sale in the US in 1993. Its protection against STIs is inferior to that of male condoms. Internal condoms can be used by the receptive partner during anal sex.

<span class="mw-page-title-main">HIV/AIDS in Malawi</span> Impact of the immunodeficiency virus in the African nation

As of 2012, approximately 1,100,000 people in Malawi are HIV-positive, which represents 10.8% of the country's population. Because the Malawian government was initially slow to respond to the epidemic under the leadership of Hastings Banda (1966–1994), the prevalence of HIV/AIDS increased drastically between 1985, when the disease was first identified in Malawi, and 1993, when HIV prevalence rates were estimated to be as high as 30% among pregnant women. The Malawian food crisis in 2002 resulted, at least in part, from a loss of agricultural productivity due to the prevalence of HIV/AIDS. Various degrees of government involvement under the leadership of Bakili Muluzi (1994–2004) and Bingu wa Mutharika (2004–2012) resulted in a gradual decline in HIV prevalence, and, in 2003, many people living in Malawi gained access to antiretroviral therapy. Condoms have become more widely available to the public through non-governmental organizations, and more Malawians are taking advantage of HIV testing services.

Cases of HIV/AIDS in Peru are considered to have reached the level of a concentrated epidemic.

The Catholic Church is a major provider of medical care to HIV/AIDS patients. Much of its work takes place in developing countries, although it has also had a presence in the global north. Its opposition to condoms, despite their effectiveness in preventing the spread of HIV, has invited criticism from public health officials and anti-AIDS activists.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

<span class="mw-page-title-main">Birth control in the United States</span> History of birth control in the United States

Birth control in the United States is available in many forms. Some of the forms available at drugstores and some retail stores are male condoms, female condoms, sponges, spermicides, and over-the-counter emergency contraception. Forms available at pharmacies with a doctor's prescription or at doctor's offices are oral contraceptive pills, patches, vaginal rings, diaphragms, shots/injections, cervical caps, implantable rods, and intrauterine devices (IUDs). Sterilization procedures, including tubal ligations and vasectomies, are also performed.

The Population and Community Development Association (PDA) is a non-governmental organization in Thailand. Its goal is to reduce poverty through both development initiatives and family planning programs. Originally called the Community-Based Family Planning Service, it was founded by Mechai Viravaidya in 1974. In the early 1970s, Viravaidya was the Minister of Industry but became frustrated with the government's inability to implement a national family planning policy. In his work with the government, he identified a direct correlation between Thailand's poverty and population growth. His immediate concern was the high population growth rate of 3.2%, which equated to approximately seven children per family. The population growth rate was an increasing concern for Thailand and Mechai Viravaidya because high growth rates restricted Thailand's ability to provide for its entire population and improve living conditions. By 2011, Thailand's population growth rate was only 0.566%. A sharp reduction in poverty has followed upon the reduction in family size, a reduction which can in significant part be attributed to the influence and programs of the PDA.

<span class="mw-page-title-main">Nancy T. Chang</span> Biochemist

Nancy Tang Chang, née Tang Nanshan, is a biochemist who cofounded Tanox in 1986 to address medical needs in the areas of allergy, asthma, inflammation and diseases affecting the human immune system. Tanox took an innovative approach in developing an asthma drug that focused on the allergy-related basis of asthma, Xolair. In June 2003, the U.S. Food and Drug Administration (FDA) approved Xolair, the first biotech product cleared for treating those with asthma related to allergies. Tanox was also active in the development of TNX-355, an antibody for the treatment of HIV/AIDS. In 2007, Tanox was sold to Genentech for $919 million. Dr. Chang grew Tanox from an idea to a substantial publicly traded company, doing innovative science. Following her success with Tanox, she has become an angel investor in health-care entrepreneurships and performs philanthropic work in community health-education projects.

S3 Safe Sex Store is the assumed name of the Michigan corporation, BAK, INC. The business offers sexual health products, sexual health information and education, free HIV testing and counseling. Community outreach is offered through an affiliated nonprofit entity of BAK, INC. called, SHARE.

Ruth L. Lockhart is an American women's health advocate, women's rights activist, AIDS educator, and feminist. She is a co-founder of Mabel Wadsworth Women's Health Center, was its executive director Bangor, Maine, from 1992 to 2015, and previously worked in health education and AIDS education for the City of Bangor and the University of Maine. She was inducted into the Maine Women's Hall of Fame in 2012.

Multipurpose prevention technologies (MPTs) are a class of products designed to address at least two health issues simultaneously, often focusing on sexual and reproductive health which includes contraception, human immunodeficiency virus (HIV) prevention, other sexually transmitted infection (STI) preventions, such as genital infection by human simplex virus (HSV) infection and human papillomavirus (HPV) infection. For example, MPTs can combine contraception and HIV prevention, contraception and other STI prevention, or the prevention of multiple STIs. Since the simultaneous use of multiple products with a single indication against each specific sexual and reproductive health issue is inconvenient, this method may affect adherence. As a result, the goal of developing a MPT as an all-in-one product is to combat this issue.

<span class="mw-page-title-main">Women in Lesotho</span> Overview of the status of women in Lesotho

In 2017, 1.1 million women were living in Lesotho, making up 51.48% of the population. 33% of women are under 15 years of age, 61.4% are between 15 and 64 years old and 5.3% are over 64 years old. They received full legal status in 2008 with the passage of The Lesotho Bank Savings and Development Act of 2008. Women in Lesotho die at a disproportionate rate from HIV/AIDs. Historically, women have wielded power as heads of households, with control over household financial decisions. The government has taken steps to ensure more equal representation of genders in government with quotas, and women in Lesotho are more highly educated than men. Still, domestic abuse, sexual violence, lack of social mobility, and aforementioned health crises are persistent issues. Social and economic movements, like the mass immigration of men to South Africa, and the rise of the garment industry, have contributed to both the progress and problems facing women in Lesotho today.

<span class="mw-page-title-main">Adaora Adimora</span> Professor of Medicine and epidemiology

Adaora Alise Adimora is an American doctor and academic. She is the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centers on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work has highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.

<span class="mw-page-title-main">Elizabeth Ngugi</span> Nurse and public health researcher

Elizabeth Ngugi was a Kenyan Professor of Community Health at the University of Nairobi, and a nurse by trade. Her major contributions to her university's program was her research and work with local prostitutes to prevent HIV/AIDS transmission. Ngugi is described as the first Kenyan nurse to become a professor.

References

  1. 1 2 "Mary Ann Leeper, PhD".
  2. 1 2 Hope, Gibbs. "100 Truly Amazing Women". trulyamazingwomen.com.
  3. "Personal Web Page - Mary Ann Leeper". faculty.darden.virginia.edu. Retrieved 2015-12-08.
  4. "Female condoms: Is this the future of safe sex?". The Independent. 2014-03-05. Retrieved 2015-12-08.
  5. "100 Truly Amazing Women: Mary Ann Leeper, senior strategist, Female Health Company". trulyamazingwomen.com. Retrieved 2015-12-08.